Neutralizing Antibody Correlates Analysis of Tetravalent Dengue Vaccine Efficacy Trials in Asia and Latin America-Reference-Cited by-同舟云学术

Neutralizing Antibody Correlates Analysis of Tetravalent Dengue Vaccine Efficacy Trials in Asia and Latin America

Published:2017-11-29 Issue:5 Volume:217 Page:742-753
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Moodie Zoe¹,Juraska Michal¹,Huang Ying¹²,Zhuang Yingying²,Fong Youyi¹²,Carpp Lindsay N¹,Self Steven G¹²,Chambonneau Laurent³,Small Robert⁴,Jackson Nicholas⁵,Noriega Fernando⁴,Gilbert Peter B¹²

Affiliation:

1. Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington

2. Department of Biostatistics, University of Washington, Seattle

3. Sanofi Pasteur, Marcy-L’Etoile, France

4. Sanofi Pasteur, Swiftwater, Pennsylvania

5. Sanofi Pasteur, Lyon, France

Funder

National Institutes of Health

National Institute of Allergy and Infectious Diseases

Department of Health and Human Services

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/217/5/742/24263243/jix609.pdf

Reference42 articles.

1. Nomenclature for immune correlates of protection after vaccination;Plotkin;Clin Infect Dis,2012

2. Correlates of protection induced by vaccination;Plotkin;Clin Vaccine Immunol,2010

3. Dengue virus neutralizing antibody levels associated with protection from infection in thai cluster studies;Buddhari;PLoS Negl Trop Dis,2014

4. Neutralizing antibody titers against dengue virus correlate with protection from symptomatic infection in a longitudinal cohort;Katzelnick;Proc Natl Acad Sci U S A,2016

5. A prospective nested case-control study of Dengue in infants: rethinking and refining the antibody-dependent enhancement dengue hemorrhagic fever model;Libraty;PLoS Med,2009

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy, public health impact and optimal use of the Takeda dengue vaccine;2024-08-11

2. Primary exposure to Zika virus is linked with increased risk of symptomatic dengue virus infection with serotypes 2, 3, and 4, but not 1;Science Translational Medicine;2024-05-29

3. Predicting the infecting dengue serotype from antibody titre data using machine learning;2024-05-27

4. Envelope-dimer epitope-like broadly protective antibodies against dengue in children following natural infection and vaccination;2024-05-01

5. Dengue virus IgG and serotype-specific neutralizing antibody titers measured with standard and mature viruses are associated with protection;2024-04-12